These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 17137717)

  • 41. Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma.
    Takita J; Hayashi Y; Kohno T; Yamaguchi N; Hanada R; Yamamoto K; Yokota J
    Cancer Res; 1997 Mar; 57(5):907-12. PubMed ID: 9041193
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Determination of DNA and RNA Methylation in Circulating Tumor Cells by Mass Spectrometry.
    Huang W; Qi CB; Lv SW; Xie M; Feng YQ; Huang WH; Yuan BF
    Anal Chem; 2016 Jan; 88(2):1378-84. PubMed ID: 26707930
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients.
    Anker P; Mulcahy H; Chen XQ; Stroun M
    Cancer Metastasis Rev; 1999; 18(1):65-73. PubMed ID: 10505546
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blood-based biomarkers for diagnosis, prognosis and treatment of colorectal cancer.
    Yörüker EE; Holdenrieder S; Gezer U
    Clin Chim Acta; 2016 Apr; 455():26-32. PubMed ID: 26797671
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of aberrant p16 methylation in the serum of colorectal cancer patients.
    Zou HZ; Yu BM; Wang ZW; Sun JY; Cang H; Gao F; Li DH; Zhao R; Feng GG; Yi J
    Clin Cancer Res; 2002 Jan; 8(1):188-91. PubMed ID: 11801557
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer.
    Jarmalaite S; Kannio A; Anttila S; Lazutka JR; Husgafvel-Pursiainen K
    Int J Cancer; 2003 Oct; 106(6):913-8. PubMed ID: 12918069
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of BRAF-V600E and V600K in melanoma circulating tumour cells by droplet digital PCR.
    Reid AL; Freeman JB; Millward M; Ziman M; Gray ES
    Clin Biochem; 2015 Oct; 48(15):999-1002. PubMed ID: 25523300
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Global Characterization of Circulating Nucleic Acids.
    Dunaeva M; Pruijn GJM
    Methods Mol Biol; 2020; 2063():257-268. PubMed ID: 31667775
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circulating free tumor DNA and colorectal cancer.
    Lecomte T; Ceze N; Dorval E; Laurent-Puig P
    Gastroenterol Clin Biol; 2010 Dec; 34(12):662-81. PubMed ID: 20832215
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inverse relationship between microsatellite instability and K-ras and p53 gene alterations in colon cancer.
    Samowitz WS; Holden JA; Curtin K; Edwards SL; Walker AR; Lin HA; Robertson MA; Nichols MF; Gruenthal KM; Lynch BJ; Leppert MF; Slattery ML
    Am J Pathol; 2001 Apr; 158(4):1517-24. PubMed ID: 11290569
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blood Worth Bottling: Circulating Tumor DNA as a Cancer Biomarker.
    Christie EL; Dawson SJ; Bowtell DD
    Cancer Res; 2016 Oct; 76(19):5590-5591. PubMed ID: 27698187
    [No Abstract]   [Full Text] [Related]  

  • 52. Carcinogenic alterations in murine liver, lung, and uterine tumors induced by in utero exposure to ionizing radiation.
    Lumniczky K; Antal S; Unger E; Wunderlich L; Hidvégi EJ; Sáfrány G
    Mol Carcinog; 1998 Feb; 21(2):100-10. PubMed ID: 9496910
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
    Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
    Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alterations of the INK4a-ARF gene locus in pleomorphic adenoma of the parotid gland.
    Weber A; Langhanki L; Schütz A; Wittekind C; Bootz F; Tannapfel A
    J Pathol; 2002 Nov; 198(3):326-34. PubMed ID: 12375265
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circulating nucleic acids in plasma or serum (CNAPS) as prognostic and predictive markers in patients with solid neoplasias.
    Goebel G; Zitt M; Zitt M; Müller HM
    Dis Markers; 2005; 21(3):105-20. PubMed ID: 16276004
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aberrant promoter hypermethylation in serum DNA from patients with silicosis.
    Umemura S; Fujimoto N; Hiraki A; Gemba K; Takigawa N; Fujiwara K; Fujii M; Umemura H; Satoh M; Tabata M; Ueoka H; Kiura K; Kishimoto T; Tanimoto M
    Carcinogenesis; 2008 Sep; 29(9):1845-9. PubMed ID: 18632757
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of BAT-26 as an indicator of microsatellite instability in gallbladder carcinomas.
    Saetta A; Koilakou SV; Michalopoulos NV; Davaris PS
    Hepatogastroenterology; 2003; 50(54):1799-802. PubMed ID: 14696408
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Methods for isolation and genetic analysis of circulating tumor DNA in patient plasma.
    Kawaguchi T; Holland WS; Gumerlock PH
    Methods Mol Med; 2003; 85():257-62. PubMed ID: 12710213
    [No Abstract]   [Full Text] [Related]  

  • 59. Correlation among pathology, genetic and epigenetic profiles, and clinical outcome in oligodendroglial tumors.
    Kuo LT; Kuo KT; Lee MJ; Wei CC; Scaravilli F; Tsai JC; Tseng HM; Kuo MF; Tu YK
    Int J Cancer; 2009 Jun; 124(12):2872-9. PubMed ID: 19330828
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis.
    Esteller M; Toyota M; Sanchez-Cespedes M; Capella G; Peinado MA; Watkins DN; Issa JP; Sidransky D; Baylin SB; Herman JG
    Cancer Res; 2000 May; 60(9):2368-71. PubMed ID: 10811111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.